期刊
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
卷 -, 期 27, 页码 4279-4286出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.201200450
关键词
Medicinal chemistry; Imaging agents; Rhenium; Technetium; Alzheimer's disease
资金
- John S. Latsis Public Benefit Foundation
The 2-(4'-aminophenyl)-6-methylbenzothiazole that is known to display affinity and specificity toward the amyloid plaques of Alzheimer's disease (AD) has been joined to the tricarbonyl [M(CO)3NNO] chelate (M = Re, 99Tc, and 99mTc) through a five-carbon linker chain to generate the neutral complex 1 (namely, Re-1 for M = Re; 99Tc-1 for M = 99Tc; and 99mTc-1 for M = 99mTc) with the aim of developing a single-photon emission computed tomography (SPECT) radiodiagnostic agent for AD. Re-1 was characterized by spectroscopic methods and X-ray crystallography, whereas the detailed NMR spectroscopic analysis of 99Tc-1 demonstrated its structural similarity to Re-1. Complexes Re-1 and 99Tc-1 display selective binding affinity for amyloid plaques as evidenced by fluorescence spectroscopy, whereas the biodistribution data of 99mTc-1?characterized by relatively low brain uptake, fast clearance from brain and blood, and in vivo stability?are considered encouraging for further elaboration on the structural features of 1 in the direction of increased brain uptake.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据